About Dana Kelly, PhD
Dr. Dana Kelly is a Clinical Neuropsychologist at the MGH Psychology Assessment Center (PAC), Instructor at Harvard Medical School, and a Licensed Clinical Psychologist in Massachusetts and Rhode Island.Dr. Kelly performs neuropsychological evaluations of adults, including extensive work with the older adult (age 65+) population. She specializes in neurodegenerative disorders, including Alzheimer's disease, Lewy body dementia, and frontotemporal disorders. She also has clinical expertise in normal pressure hydrocephalus, cerebrovascular disease (e.g., stroke), epilepsy, multiple sclerosis, traumatic brain injury, functional neurological disorders, and other neuropsychiatric conditions. Dr. Kelly’s current research aims to better understand medication effects and adherence in older adults with cognitive impairment.Dr. Kelly completed undergraduate studies at the University of Michigan-Ann Arbor. She earned an M.S. and Ph.D. in clinical psychology with specialization in neuropsychology from Rosalind Franklin University of Medicine and Science. Her clinical training included a neuropsychology residency at Rush University Medical Center and a postdoctoral fellowship in clinical neuropsychology at Brown University Warren Alpert Medical School.
Clinical Interests:
- Alzheimer's Disease
- Epilepsy
- Frontotemporal Dementia
- Functional Neurological Disorder
- Multiple Sclerosis
- Neurodegenerative Disorders
- Neuropsychiatric Conditions (e.g., OCD, Depression)
- Neurovascular Conditions (e.g., Stroke)
- Normal Pressure Hydrocephalus
- Traumatic Brain Injury
Treats:
- Adult
Locations
Mass General Psychology Assessment Center
One Bowdoin Square
7th Floor
Boston, MA 02114
Phone: 617-726-3647
Medical Education
- Residency, Rush University Medical Center
- Fellowship, Warren Alpert Medical School of Brown University, Rhode Island Hospital & Miriam Hospital
Accepted Insurance Plans
- Aetna Health Inc.
- Beacon Health - ACD
- Beacon Health - PBO
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna Behavioral Health
- Commonwealth Care Alliance
- Great-West Healthcare (formally One Health Plan)
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- MassHealth
- Medicare
- Medicare - ACD
- Medicare ACO - ACD
- Medicare ACO - PBO
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Senior Whole Health
- TriCare
- Tufts Health Plan
- Unicare
- United Behavioral Health
- United Behavioral Health - MGH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Publications
-
Margolis, S., Kelly, D.A., Daiello, L.A., Davis, J., Tremont, G., Pillemer, S., Denby, C. (2020). Anticholinergic/sedative drug burden and subjective cognitive decline in older adults at risk of Alzheimer?s disease. The Journals of Gerontology: Medical Sciences. DOI: 10.1093/gerona/glaa222Abraham, M., Seidenberg, M., Kelly, D.A., Nielson, K.A., Woodard, J.L, Smith, J.C., Durgerian, S., & Rao, S.M. (2020). Episodic memory and hippocampal volume predict five-year MCI conversion in healthy APOE e4 carriers. Journal of the International Neuropsychology Society, 26(7), 733-738. DOI:10.1017/S1355617720000181Kelly, D.A., Seidenberg, M., Reiter, K., Nielson, K.A., Woodard, J.L., Smith, J.C., Durgerian, S., & Rao, S.M. (2018). Differential 5-year brain atrophy rates in cognitively declining and stable APOE-e4 elders. Neuropsychology, 32(6), 647-653. DOI: 10.1037/neu0000444Reiter, K., Nielson, K.A., Durgerian, S., Woodard, J.L., Smith J.C., Seidenberg, M., Kelly, D.A., & Rao, S.M. (2017). Five-year longitudinal brain volume change in healthy elders at genetic risk for Alzheimer?s disease. Journal of Alzheimer?s Disease, 55(4), 1363-1377. DOI: 10.3233/JAD-160504